Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for April 30th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 30th:

Karyopharm Therapeutics Inc. (KPTI - Free Report) : This pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.

Karyopharm Therapeutics Inc. Price and Consensus

Karyopharm's shares gained 16% over the last one month compared to S&P 500’s rise of 14.8%. The company possesses a Momentum Score of A.

Karyopharm Therapeutics Inc. Price

Compugen Ltd. (CGEN - Free Report) : This therapeutic discovery company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.

Compugen Ltd. Price and Consensus

Compugen’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

Compugen Ltd. Price

AngloGold Ashanti Limited (AU - Free Report) : This  gold mining company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.

AngloGold Ashanti Limited Price and Consensus

AngloGold’s shares gained 40.8% over the last one month. The company possesses a Momentum Score of A.

AngloGold Ashanti Limited Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Karyopharm Therapeutics Inc. (KPTI) - free report >>

Compugen Ltd. (CGEN) - free report >>

AngloGold Ashanti Limited (AU) - free report >>

Published in